To track the homing capacity of CD8+ T cells to the tumor microenvironment in the tumor xenograft mice in vivo, nivolumab, an anti-PD-1 antibody, was labeled with nuclear isotope indium-111 (In-111). Here, CD8A is linked to neoplasm.